Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | TG(41:2) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | - | pmol/sample |
| - | TG(41:2) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | - | pmol/sample |
| - | TG(41:2) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | - | pmol/sample |
| - | TG(41:2) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 2.94 | pmol/sample |
| - | TG(41:2) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 1.22 | pmol/sample |
| - | TG(41:2) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 1.32 | pmol/sample |
| - | TG(41:2) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 0.97 | pmol/sample |
| - | TG(41:2) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 1.1 | pmol/sample |
| - | TG(41:2) | C | 0.0 | BCD100322A01 | 0.39 | pmol/sample |
| - | TG(41:2) | C | 0.5 | BCD100322A03 | 1.31 | pmol/sample |
| - | TG(41:2) | C | 1.0 | BCD100322A07 | 0.9 | pmol/sample |
| - | TG(41:2) | C | 2.0 | BCD100322A11 | 1.76 | pmol/sample |
| - | TG(41:2) | C | 4.0 | BCD100322A15 | 0.83 | pmol/sample |
| - | TG(41:2) | C | 8.0 | BCD100322A19 | 2.07 | pmol/sample |
| - | TG(41:2) | C | 12.0 | BCD100322A23 | 2.54 | pmol/sample |
| - | TG(41:2) | C | 24.0 | BCD100322A27 | 0.51 | pmol/sample |
| - | TG(41:2) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | - | pmol/sample |
| - | TG(41:2) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 3.49 | pmol/sample |
| - | TG(41:2) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 1.52 | pmol/sample |
| - | TG(41:2) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | - | pmol/sample |
| - | TG(41:2) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 0.73 | pmol/sample |
| - | TG(41:2) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | - | pmol/sample |
| - | TG(41:2) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 0.4 | pmol/sample |
| - | TG(41:2) | 25OH-Chol | 0.5 | BCD100322A04 | 0.12 | pmol/sample |
| - | TG(41:2) | 25OH-Chol | 1.0 | BCD100322A08 | - | pmol/sample |
| - | TG(41:2) | 25OH-Chol | 2.0 | BCD100322A12 | 0.44 | pmol/sample |
| - | TG(41:2) | 25OH-Chol | 4.0 | BCD100322A16 | 4.21 | pmol/sample |
| - | TG(41:2) | 25OH-Chol | 8.0 | BCD100322A20 | 4.37 | pmol/sample |
| - | TG(41:2) | 25OH-Chol | 12.0 | BCD100322A24 | 0.89 | pmol/sample |
| - | TG(41:2) | 25OH-Chol | 24.0 | BCD100322A28 | - | pmol/sample |